tradingkey.logo

BRIEF-OnCusp Therapeutics Receives FDA Fast Track Designation For CUSP06

ReutersFeb 12, 2025 1:18 PM

-

  • ONCUSP THERAPEUTICS RECEIVES FDA FAST TRACK DESIGNATION FOR CUSP06 FOR THE TREATMENT OF PLATINUM-RESISTANT OVARIAN CANCER

Source text: ID:nPn1M3V5Za

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI